Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients

INTRODUCTION: No therapy has yet proven effective in COVID-19. Tocilizumab (TCZ) in patients with severe COVID-19 could be an effective treatment. METHOD: We conducted a retrospective case-control study in the Nord Franche-Comté Hospital, France. We compared the outcome of patients treated with TCZ...

Descripción completa

Detalles Bibliográficos
Autores principales: Klopfenstein, T., Zayet, S., Lohse, A., Balblanc, J.-C., Badie, J., Royer, P.-Y., Toko, L., Mezher, C., Kadiane-Oussou, N.J., Bossert, M., Bozgan, A.-M., Charpentier, A., Roux, M.-F., Contreras, R., Mazurier, I., Dussert, P., Gendrin, V., Conrozier, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202806/
https://www.ncbi.nlm.nih.gov/pubmed/32387320
http://dx.doi.org/10.1016/j.medmal.2020.05.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202806/
https://www.ncbi.nlm.nih.gov/pubmed/32387320
http://dx.doi.org/10.1016/j.medmal.2020.05.001

Ejemplares similares